NRX Pharmaceuticals, Inc. - stock earnings
NRXP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.1 million USD | ? USD |
| 2023Q2 | -8.7 million USD | ? USD |
| 2023Q1 | -12.6 million USD | ? USD |
| 2022Q4 | -5.7 million USD | ? USD |
| 2022Q3 | -9.0 million USD | ? USD |
| 2022Q2 | -4.4 million USD | ? USD |
| 2022Q1 | -11.2 million USD | ? USD |
| 2021Q4 | -30.8 million USD | ? USD |
| 2021Q3 | -20.8 million USD | ? USD |
| 2021Q2 | -16.0 million USD | ? USD |
| 2021Q1 | -45.1 million USD | ? USD |
| 2020Q4 | -1.1 million USD | ? USD |
| 2020Q3 | -5.2 million USD | ? USD |
| 2020Q2 | 102287 USD | ? USD |
| 2020Q1 | 273220 USD | ? USD |
| 2019Q4 | -14754 USD | ? USD |
| 2019Q3 | 59195 USD | ? USD |
| 2019Q2 | 176021 USD | ? USD |
| 2019Q1 | 187965 USD | ? USD |
| 2018Q4 | 29139 USD | ? USD |
| 2018Q3 | 28084 USD | ? USD |
| 2018Q2 | -6602 USD | ? USD |
| 2018Q1 | 15481 USD | ? USD |
| 2017Q4 | -105033 USD | ? USD |
NRXP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.1 million USD | ? USD |
| 2022 | -35.2 million USD | ? USD |
| 2021 | -71.7 million USD | ? USD |
| 2020 | -12.3 million USD | ? USD |
| 2019 | 408427 USD | ? USD |
| 2018 | 66101 USD | ? USD |
| 2017 | -105030 USD | ? USD |
NRXP
Price: $2.81
52 week price:
Earnings Per Share: -4.00 USD
P/E Ratio: -0.96
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 246900
Market Capitalization: 49.0 million